<DOC>
	<DOCNO>NCT01094483</DOCNO>
	<brief_summary>The primary hypothesis study concomitant multiple-dose administration PN 400 interfere platelet inhibitory effect enteric-coated low-dose aspirin ( 81 mg ) , measure serum thromboxane B2 inhibition .</brief_summary>
	<brief_title>A Study Assessing Inhibition Serum Thromboxane B2 Levels With PN400 Low Dose Aspirin</brief_title>
	<detailed_description />
	<mesh_term>Aspirin</mesh_term>
	<criteria>Stable without clinically significant disease Use NSAID within 2 week Type 1 2 DM GI disorder</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Thromboxane B2</keyword>
</DOC>